Affymax, Inc. is a biopharmaceutical company. It is engaged in the developing of nephrology and specialty care space by delivering innovative therapeutical offerings to patients and healthcare providers. The company was founded on July 20, 2001 and is headquartered in New York, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company